Stock Scorecard



Stock Summary for Illumina Inc (ILMN) - $135.19 as of 11/20/2024 4:12:32 PM EST

Total Score

6 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ILMN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ILMN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ILMN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ILMN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ILMN (50 out of 90)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0

Latest News for for ILMN

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2 11/20/2024 9:30:00 PM
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2 - Illumina ( NASDAQ:ILMN ) , Myriad Genetics ( NASDAQ:MYGN ) 11/20/2024 9:30:00 PM
ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio 11/20/2024 12:07:00 PM
Should You Invest in the Invesco Biotechnology & Genome ETF ( PBE ) ? 11/20/2024 11:20:00 AM
Del Mar's Last Sandlot Becomes Elevated $75 Million Oceanfront Estate 11/18/2024 6:00:00 PM
Should SPDR Portfolio S&P 400 Mid Cap ETF ( SPMD ) Be on Your Investing Radar? 11/14/2024 11:20:00 AM
Should Vanguard S&P Mid-Cap 400 Value ETF ( IVOV ) Be on Your Investing Radar? 11/12/2024 11:20:00 AM
DNA Sequencing Market Size to Hit USD 74.89 Billion by 2033 | Straits Research 11/11/2024 3:15:00 PM
Why Illumina ( ILMN ) is a Top Momentum Stock for the Long-Term 11/11/2024 2:50:00 PM
Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now? 11/11/2024 11:20:00 AM

Financial Details for ILMN

Company Overview

Ticker ILMN
Company Name Illumina Inc
Country USA
Description Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/6/2025

Stock Price History

Last Day Price 135.19
Price 4 Years Ago 359.92
Last Day Price Updated 11/20/2024 4:12:32 PM EST
Last Day Volume 3,036,315
Average Daily Volume 2,010,301
52-Week High 156.66
52-Week Low 90.96
Last Price to 52 Week Low 48.63%

Valuation Measures

Trailing PE N/A
Industry PE 27.34
Sector PE 40.32
5-Year Average PE 93.37
Free Cash Flow Ratio 22.84
Industry Free Cash Flow Ratio 102.40
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 2.43
Total Cash Per Share 5.92
Book Value Per Share Most Recent Quarter 13.45
Price to Book Ratio 10.08
Industry Price to Book Ratio 800.29
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 4.88
Industry Price to Sales Ratio Twelve Trailing Months 3.81
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 11
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 158,600,000
Market Capitalization 21,441,134,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.17%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -96.50%
Annual Earnings Growth 73.64%
Reported EPS 12 Trailing Months -9.98
Reported EPS Past Year 1.59
Reported EPS Prior Year 0.87
Net Income Twelve Trailing Months -1,585,000,000
Net Income Past Year -1,161,000,000
Net Income Prior Year -4,404,000,000
Quarterly Revenue Growth YOY -3.50%
5-Year Revenue Growth 6.21%
Operating Margin Twelve Trailing Months 0.24

Balance Sheet

Total Cash Most Recent Quarter 939,000,000
Total Cash Past Year 1,054,000,000
Total Cash Prior Year 2,037,000,000
Net Cash Position Most Recent Quarter -1,049,000,000
Net Cash Position Past Year -435,000,000
Long Term Debt Past Year 1,489,000,000
Long Term Debt Prior Year 2,735,000,000
Total Debt Most Recent Quarter 1,988,000,000
Equity to Debt Ratio Past Year 0.79
Equity to Debt Ratio Most Recent Quarter 0.52
Total Stockholder Equity Past Year 5,745,000,000
Total Stockholder Equity Prior Year 6,599,000,000
Total Stockholder Equity Most Recent Quarter 2,125,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 547,000,000
Free Cash Flow Per Share Twelve Trailing Months 3.45
Free Cash Flow Past Year 282,000,000
Free Cash Flow Prior Year -74,000,000

Options

Put/Call Ratio 1.35
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.86
MACD Signal 2.70
20-Day Bollinger Lower Band 110.63
20-Day Bollinger Middle Band 132.10
20-Day Bollinger Upper Band 153.56
Beta 1.13
RSI 36.78
50-Day SMA 126.11
150-Day SMA 183.53
200-Day SMA 241.40

System

Modified 11/21/2024 3:40:38 AM EST